Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Organic Letters|July 29, 2005
A new RNA synthetic method with a 2'-O-(2-cyanoethoxymethyl) protecting groupTadaaki Ohgi, Yutaka Masutomi, Kouichi Ishiyama, et al.
Nucleic Acids Symposium Series (2004)|December 8, 2006
A novel RNA synthetic method with a 2'-O-(2-cyanoethoxymethyl) protecting groupYoshinobu Shiba, Hidetoshi Kitagawa, Yutaka Masutomi, et al.
Journal of the American Chemical Society|June 17, 2004
Homo-N-oligonucleotides (N1/N9-C1' methylene bridge oligonucleotides): nucleic acids with left-handed helicityKouichi Ishiyama, Gerald E Smyth, Toshihiro Ueda, et al.
Nucleic Acids Symposium Series (2004)|December 8, 2006
Novel nucleic acids with left-handed helicityKouichi Ishiyama, Gerald E Smyth, Toshihiro Ueda, et al.
Nucleic Acids Symposium Series (2004)|November 22, 2007
Chemical synthesis of a very long RNA oligomer, a 110mer precursor-miRNA candidate, with 2-cyanoethoxymethyl (CEM) as the 2'-O-protecting groupHirofumi Masuda, Yoshinobu Shiba, Naoki Watanabe, et al.
Nucleic Acids Research|April 27, 2007
Chemical synthesis of a very long oligoribonucleotide with 2-cyanoethoxymethyl (CEM) as the 2'-O-protecting group: structural identification and biological activity of a synthetic 110mer precursor-microRNA candidateYoshinobu Shiba, Hirofumi Masuda, Naoki Watanabe, et al.
Radiology|January 19, 2013
Use of CT to evaluate pleural invasion in non-small cell lung cancer: measurement of the ratio of the interface between tumor and neighboring structures to maximum tumor diameterKazuhiro Imai, Yoshihiro Minamiya, Kouichi Ishiyama, et al.
Clinical Imaging|March 22, 2014
New CT criteria for nodal staging in non-small cell lung cancerSatoshi Kudo, Kazuhiro Imai, Kouichi Ishiyama, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 1, 2004
Antitumor activity of small interfering RNA/cationic liposome complex in mouse models of cancerJunichi Yano, Kazuko Hirabayashi, Shin-Ichiro Nakagawa, et al.
Anticancer Research|July 26, 2017
Metabolic Rather than Pathological Response to Preoperative Chemoradiotherapy Is a Stronger Predictor of Survival in cStage IIB-IV Esophageal CancerSatoru Motoyama, Yusuke Sato, Kiyotomi Maruyama, et al.
Pageof 1